Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Japan. This a clinical trial to study the efficacy and safety of
three times a day BIAsp-70 compared to two times a day BIAsp-30 in subjects with type 2
diabetes.